States Study Economic Conversion

BOSTON—An informal network of local and state activists is using economic rather than political arguments in a campaign to divert spending on military R&D to civilian projects. The effort to reduce a local economy's dependence on defense con tracts and replace it with a variety of civilian R&D projects is known most often as economic conversion, although it goes by a variety of other names. Based on a desire to avoid the historical fluctuations in funding that have plagued communities who

Written byJoseph Hixson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The effort to reduce a local economy's dependence on defense con tracts and replace it with a variety of civilian R&D projects is known most often as economic conversion, although it goes by a variety of other names. Based on a desire to avoid the historical fluctuations in funding that have plagued communities whose scientists and engineers work chiefly for defense con tractors, the movement has gained support from those who seethe latest buildup in military spending coming to an end. But disagreement remains on the economic impact of such conversion efforts.

A bill passed June 2 by Connecticut legislators provides $12,000 in seed money for a permanent task force on manufacturing that hopes to offer incentives and capital to companies that switch from military to civilian projects. The bill's sponsor, State Rep. Sean McNally, expects leaders from education, labor and business to use the task force to plot the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies